STAT Plus: Pharmalittle: Canadian ambassador says imports would not lower U.S. prices; can the Sackler legacy be rebuilt?

Good morning, everyone, and how are you today? We are doing just fine, thank you, now that the Pharmalot campus has settled down. The shortest person has left for the local schoolhouse for another day of learning and our official mascot is cozily snoozing in his favorite corner. This leaves us to the usual routine of heating the coffee kettle, quaffing cups of stimulation (pumpkin spice is back in favor), and foraging for items of interest. Speaking of which, here are a few tidbits to get you going. No time like now, yes? So onward we go. Hope you have a smashing day and, as always, do drop us a line when you run across classified material and other saucy news …

Canada does not have a large enough supply of prescription drugs to meet U.S. demand, and importing medicines from Canada would not significantly lower U.S. prices, Ottawa’s acting ambassador told U.S. officials in recent meetings, Reuters writes. Kirsten Hillman, Canada’s acting ambassador to the U.S., says her country is “sympathetic to U.S. concerns regarding affordable prescription drugs. Not only are we too small of a market, Canada cannot increase its domestic pharmaceutical drug supply to meet U.S. demand.”

Continue to STAT Plus to read the full story…

Read Original Article: STAT Plus: Pharmalittle: Canadian ambassador says imports would not lower U.S. prices; can the Sackler legacy be rebuilt? »